SCHEMBL24104221

SCHEMBL24104221

BC(B)(B)c1cc2cnc(NC3CCN(SC)CC3)nc2[nH]c1=O

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MAPK14 Q16539 1/20 0.39
▸ CDK2 P24941 16/20 0.38
▸ CCNE1 P24864 14/20 0.38
▸ CCND1 P24385 11/20 0.38
▸ CDK6 Q00534 11/20 0.38
▸ CCNA2 P20248 2/20 0.36
▸ CDK7 P50613 2/20 0.36
▸ CCNH P51946 2/20 0.36
▸ MNAT1 P51948 2/20 0.36
▸ MAPK8 P45983 2/20 0.36
▸ MAPK9 P45984 1/20 0.36
▸ MAPK10 P53779 1/20 0.36
▸ CCNE2 O96020 2/20 0.36
▸ CCNT1 O60563 5/20 0.35
▸ CDK4 P11802 5/20 0.35
▸ CDK9 P50750 5/20 0.35
▸ MAPK7 Q13164 1/20 0.34
▸ CCND3 P30281 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24103609 0.92 CDK2 (0.41) MAPK14CDK2CCNE1CCND1CDK6
SCHEMBL23341176 0.85 BRD4 (0.46) MAPK14CDK2CCNE1CCND1CDK6
SCHEMBL23340858 0.84 CDK2 (0.44) MAPK14CDK2CCNE1CCND1CDK6
SCHEMBL22259521 0.81 CDK2 (0.46) MAPK14CDK2CCNE1CCND1CDK6
SCHEMBL23340998 0.81 CDK2 (0.46) MAPK14CDK2CCNE1CCND1CDK6
SCHEMBL23340889 0.80 CDK2 (0.48) MAPK14CDK2CCNE1CCND1CDK6
SCHEMBL23340800 0.80 CDK2 (0.48) MAPK14CDK2CCNE1CCND1CDK6
SCHEMBL23340918 0.78 CDK2 (0.47) MAPK14CDK2CCNE1CCND1CDK6
SCHEMBL23340731 0.78 MAPK8 (0.57) CDK2CCNE1CCND1CDK6CCNA2
SCHEMBL23340894 0.75 BRD4 (0.45) MAPK14CDK2CCNE1CCND1CDK6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021249258-A1 DEUTERATED PYRIDOPYRIMIDINONES AND THEIR USE AS HIGHLY SELECTIVE CYCLIN-DEPENDENT KINASE 2 INHIBITORS ZENTAUR THERAPEUTICS INTERNATIONAL LIMITED (CN) 2021-12-16 — — WO disclosed
Send feedback